June 15, 2020

ProSciento, Clinical Research Organization (CRO) Focused on Metabolic Diseases, Institutes Rapid COVID-19 Antigen and Antibody Testing at Clinical Research Unit in Southern California Read More »

February 11, 2020

ProSciento Appoints Dr. Michael Grimm as Chief Medical Officer Read More »

ProSciento - Top Work Places


View Our Presentation


July 8, 2020

184 Insulin Sensitivity and Glucose Metabolism of Olanzapine and Combination Olanzapine and Samidorphan: A Phase 1 Exploratory Study in Healthy Volunteers Read More »

July 8, 2020

Pharmacokinetic and Dose-Finding Studies on Efpeglenatide in Patients With Type 2 Diabetes Read More »

December 14, 2019

Sotagliflozin Decreases Postprandial Glucose and Insulin Concentrations by Delaying Intestinal Glucose Absorption Read More »

Learn about ProSciento services for COVID-19 clinical studies in healthy subjects